期刊文献+

TRPC6介导DU145细胞条件培养液诱导人脐静脉内皮细胞增殖的研究 被引量:1

TRPC6 mediates the proliferation of human umbilical vein endothelial cells induced by DU145 conditioned medium
原文传递
导出
摘要 目的探讨瞬时受体势C6(TRPC6,transient receptor potential canonical6)在人前列腺癌细胞(DU145)的培养上清液诱导人脐静脉血管内皮细胞(hUVEC)增殖中的作用。方法以DU145细胞培养上清液和DMEM培养基的不同比例混合液培养的hUVEC细胞。MTF法检测细胞增殖情况的变化;PCR和Western-blot法分别检测TRPC6基因和蛋白的表达情况。结果hUVEC经前列腺癌细胞培养上清液作用48h后,细胞增殖明显增加,TRPC6基因和蛋白的表达上调。结论前列腺癌细胞培养上清液能明显促进人脐静脉内皮细胞的增殖,其机制可能是通过上调TRPC6来介导。 Objective To investigate the influence of transient receptor potential canonical 6 (TR- PC6) on the proliferation of hUVEC induced by the supernatant from human prostate cancer cells (DU145). Methods Experiment group was treated with the mixture of DU145 cells supernatant and DMEM medium in different ratio, control group was treated with DMEM medium. The change of cell proliferation was detected by MTT method, and TRPC6 gene and protein was detected by PCR and Western-blot methods respectively. Results After incubated for 48h with the supernatant from cultured DUI45 cells, the population of hUVECs increased obviously, and the expression of TRPC6 genes and protein had clearly up-regulation. Conclusion The supernatant from cultured DU145 cells could effectively enhance the proliferation of hUVECs. The mechanisms might be that the proliferation of human umbilical vein endothelial cells was mediated by TRPC6.
出处 《中国医师杂志》 CAS 2011年第1期12-15,共4页 Journal of Chinese Physician
基金 辽宁省科学技术计划基金项目(2010225034)
关键词 瞬时受体电位通道/代谢 前列腺肿瘤 肿瘤细胞 培养的 内皮细胞 脐静脉 细胞增殖 Transient receptor potential channels/ME Prostatic neoplasms Tumor ceils, cultured Endothelial cells Umbilical veins Cell proliferation
  • 相关文献

参考文献2

二级参考文献23

  • 1DEMAUREX N,DISTELHORST C,et al.Apoptosis-the calcium connection[J].Science,2003,300(5616):65-67.
  • 2SCORRANO,LUCA,OAKES,et al.BAX and BAK regulation of endoplasmic reticulum Ca2+:a control point for apoptosis[J].Science,2003,300(5616):135-139.
  • 3KANG J H,ZHENG RL.Dose-dependent regulation of superoxide anion on the proliferation,differentiation,apoptosis and necrosis of human hepatoma cells:the role of intracellular Ca2+[J].Redox Rep,2004,9 (1):37-48.
  • 4MICHAEL J.BERRIDGE,PETER L,et al.The versatility and universality of calcium signaling[J].Nat Rev,2000,1 (1):11-21.
  • 5SCHMITZ C,PERRAUD A L,JOHNSON C O.Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7[J].Cell,2003,114(2):191-200.
  • 6NICOTERA P,BANO D.The enemy at the gates:Ca2+ entry through TRPM7 channels and anoxic neuronal death[J].Cell,2003,115(7):768-770.
  • 7CRAIG M,LUTZ B,VEIT F.The TRP channels,a remarkably functional family[J].Cell,2002,108(5):595-598.
  • 8David E.Clapham.TRP channels as cellular sensors[J].Nature,2003,426 (6966):517-524.
  • 9CARSTEN S B,GRIGORY K,LUBA K,et al.TRPC1 and TRPC5 form a novel cation channel in mammalian brain[J].Neuron,2001,29 (3):645-655.
  • 10HUANG CL.The transient receptor potential superfamily of ion channels[J].J Am Soc Nephrol,2004,15 (7):1690-1699.

共引文献14

同被引文献23

  • 1Bell J, McFadden G. Viruses for tumor therapy[J]. Cell Host Mi- crobe, 2014,15 (3) :260-265.
  • 2Galanis E, Atherton PJ, Maurer M J, et al. Oncolytic measles vi- res expressing the sodium iodide symporter to treat drug-resistant o- varian cancer [J]. Cancer Res, 2015 ,75(1) :22-30.
  • 3Ilkow CS, Swift SL, Bell JC,et al. From scourge to cure: tumour- selective viral pathogenesis as a new strategy against cancer [ J]. PLoS Pathog, 2014,10 ( 1 ) : e1003836.
  • 4Cattaneo R, Miest T, Shashkova EV, et al. Reprogrammed viru- ses as cancer therapeutics : targeted, armed and shielded [ J]. Nat Rev Microbiol, 2008, 6(7): 529-540.
  • 5Parker JN, Bauer DF, Cody JJ, et al. Oncolytic viral therapy of malignant glioma [ J ]. Neurotherapeutics, 2009,6 ( 3 ) :558-569.
  • 6Jing x/, Zaias J, Duncan R,et al. In vivo safety, biodistribution and antitumor effects of uPAR retargeted oncolytic measles virus in syngeneic cancer models[J]. Gene Ther, 2014,21 (3) :289-297.
  • 7Sato D, Kurihara Y, Kondo S, et al. Antitumor effects of telomer- ase-specific replication-selective oncolytic viruses for adenoid cyst- ic carcinoma cell lines [J]. Oncol Rep, 2013, 30(6) : 2659- 2664.
  • 8Longo SL, Griffith C, Glass A, et al. Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promot- er[J]. Cancer Gene Ther, 2011, 18(2) : 123-134.
  • 9Lu Y, Zhang Y, Chang G, et al. Comparison of prostate-specific promoters and the use of PSP-driven virotherapy for prostate cancer [J]. Biomed Res Int,2013 ,2013 :624632.
  • 10Zhang K J, Zhang J, Wu YM, et al. Complete eradication of hep- aromas using an oncolytic adenovirus containing AFP promoter controlling E1A and an E1B deletion to drive IL-24 expression [J]. Cancer Gene Ther, 2012, 19(9) : 619-629.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部